Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | MAT2A | P31153 | 2/20 | 0.30 |
| ▸ | CCR9 | P51686 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23576662 | 1.00 | FNTA (0.36) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL23601617 | 0.93 | FNTA (0.36) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL29909025 | 0.89 | FNTA (0.37) | FNTAFNTBTP53MAPTCSNK2A2 | |
| SCHEMBL23577131 | 0.89 | FNTA (0.37) | FNTAFNTBTP53MAPTCSNK2A2 | |
| SCHEMBL23601645 | 0.89 | FNTA (0.36) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL23600551 | 0.88 | FNTA (0.40) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL29909786 | 0.88 | FNTA (0.36) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL23576904 | 0.88 | FNTA (0.36) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL23576916 | 0.87 | FNTA (0.36) | FNTAFNTBTP53MAPTPOLB | |
| SCHEMBL23601440 | 0.85 | FNTA (0.34) | FNTAFNTBTP53MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4081305-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | Carna Biosciences, Inc. (JP) | 2022-11-02 | — | — | EP | disclosed |